1. Paux, G. and Dmitrienko, A. Clinical trial optimization approaches to phase III trials with multiple objectives. Journée annuelle Biopharmacie et Santé (B&S). Nov 6, 2017.
  2. Paux, G. and Bonnet, N. Implementation of Bayesian quantitative decision-making to early drug development. PSI Annual Conference. Jun 1, 2019.
  3. Paux, G. and Mi, G. 3ODM x PtW, a quantitative framework combining PoC assessment and optimal dose selection in a randomized phase 2 trial. 2023 American Statistical Association - Regulatory-Industry Statistical Workshop. Sep 29, 2023.